{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:22:30Z","timestamp":1785410550333,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1597"],"award-info":[{"award-number":["2026NSFSC1597"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["00402054A19VD"],"award-info":[{"award-number":["00402054A19VD"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1\u00b73\u00b75 Project for Disciplines of Excellence in Artificial Intelligence, West China Hospital, Sichuan University","award":["ZYAI24024"],"award-info":[{"award-number":["ZYAI24024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"DOI":"10.1007\/s13679-026-00726-3","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:15:10Z","timestamp":1781154910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Refining the Bariatric Journey: A Proposed Neoadjuvant and Adjuvant Framework for GLP-1 Receptor Agonists Inspired by Oncology"],"prefix":"10.1007","volume":"15","author":[{"given":"Ke","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Ka-kei","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-6147","authenticated-orcid":false,"given":"Jason","family":"Widjaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-4060","authenticated-orcid":false,"given":"HaiYang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-6097","authenticated-orcid":false,"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"10431","key":"726_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027\u201350.","journal-title":"Lancet"},{"issue":"1","key":"726_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mcna.2017.08.005","volume":"102","author":"AG Tsai","year":"2018","unstructured":"Tsai AG, Remmert JE, Butryn ML, Wadden TA. Treatment of Obesity in Primary Care. Med Clin North Am. 2018;102(1):35\u201347.","journal-title":"Med Clin North Am"},{"issue":"3","key":"726_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00268-018-4847-8","volume":"43","author":"A Vitiello","year":"2019","unstructured":"Vitiello A, Angrisani L, Santonicola A, Iovino P, Pilone V, Forestieri P. Bariatric Surgery Versus Lifestyle Intervention in Class I Obesity: 7-10-Year Results of a Retrospective Study. World J Surg. 2019;43(3):758\u201362.","journal-title":"World J Surg"},{"issue":"1","key":"726_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11695-018-3525-0","volume":"29","author":"PE O\u2019Brien","year":"2019","unstructured":"O\u2019Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, Crosthwaite G, Brown W. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obes Surg. 2019;29(1):3\u201314.","journal-title":"Obes Surg"},{"issue":"11","key":"726_CR5","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/ajg.2017.241","volume":"112","author":"AR Schulman","year":"2017","unstructured":"Schulman AR, Thompson CC. Complications of Bariatric Surgery: What You Can Expect to See in Your GI Practice. Am J Gastroenterol. 2017;112(11):1640\u201355.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"726_CR6","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s00464-021-08329-w","volume":"35","author":"DI Athanasiadis","year":"2021","unstructured":"Athanasiadis DI, Martin A, Kapsampelis P, Monfared S, Stefanidis D. Factors associated with weight regain post-bariatric surgery: a systematic review. Surg Endosc. 2021;35(8):4069\u201384.","journal-title":"Surg Endosc"},{"issue":"13","key":"726_CR7","doi-asserted-by":"publisher","first-page":"10449","DOI":"10.3390\/ijms241310449","volume":"24","author":"MS Popoviciu","year":"2023","unstructured":"Popoviciu MS, P\u0103duraru L, Yahya G, Metwally K, Cavalu S. Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials. Int J Mol Sci. 2023;24(13):10449.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"726_CR8","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","volume":"37","author":"M Ilanga","year":"2023","unstructured":"Ilanga M, Heard JC, McClintic J, Lewis D, Martin G, Horn C, Khorgami Z, Richards J, Chow GS, Lim RB. Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study. Surg Endosc. 2023;37(12):9509\u201313.","journal-title":"Surg Endosc"},{"issue":"3","key":"726_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11695-014-1563-9","volume":"25","author":"P Iglesias","year":"2015","unstructured":"Iglesias P, Civantos S, Vega B, Pav\u00f3n I, Guijarro G, Monereo S. Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery. Obes Surg. 2015;25(3):575\u20138.","journal-title":"Obes Surg"},{"key":"726_CR10","doi-asserted-by":"crossref","unstructured":"Agha RA, Mathew G, Rashid R, Kerwan A, Al-Jabir A, Sohrabi C, Franchi T, Nicola M, Agha M, TITAN Group. Transparency In The reporting of Artificial Intelligence\u2013the TITAN guideline. Premier J Sci. 2025:10100082.","DOI":"10.70389\/PJS.100082"},{"key":"726_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.metabol.2017.12.010","volume":"79","author":"BT Phillips","year":"2018","unstructured":"Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: Development of standards for patient safety and efficacy. Metabolism. 2018;79:97\u2013107.","journal-title":"Metabolism"},{"issue":"11","key":"726_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.soard.2024.05.009","volume":"20","author":"M De Luca","year":"2024","unstructured":"De Luca M, Shikora S, Eisenberg D, Angrisani L, Parmar C, Alqahtani A, Aminian A, Aarts E, Brown WA, Cohen RV, Di Lorenzo N, Faria SL, Goodpaster KPS, Haddad A, Herrera MF, Rosenthal R, Himpens J, Iossa A, Kermansaravi M, Kow L, Kurian M, Chiappetta S, LaMasters T, Mahawar K, Merola G, Nimeri A, O\u2019Kane M, Papasavas PK, Piatto G, Ponce J, Prager G, Pratt JSA, Rogers AM, Salminen P, Steele KE, Suter M, Tolone S, Vitiello A, Zappa M, Kothari SN. Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO\/ASMBS). Surg Obes Relat Dis. 2024;20(11):991\u20131025.","journal-title":"Surg Obes Relat Dis"},{"key":"726_CR13","doi-asserted-by":"publisher","first-page":"1014901","DOI":"10.3389\/fendo.2022.1014901","volume":"13","author":"J Widjaja","year":"2022","unstructured":"Widjaja J, Chu Y, Yang J, Wang J, Gu Y. Can we abandon foregut exclusion for an ideal and safe metabolic surgery? Front Endocrinol (Lausanne). 2022;13:1014901.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"726_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.suc.2016.03.007","volume":"96","author":"T Fouse","year":"2016","unstructured":"Fouse T, Brethauer S. Resolution of Comorbidities and Impact on Longevity Following Bariatric and Metabolic Surgery. Surg Clin North Am. 2016;96(4):717\u201332.","journal-title":"Surg Clin North Am"},{"issue":"5","key":"726_CR15","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1381\/096089203322509309","volume":"13","author":"ML Schwartz","year":"2003","unstructured":"Schwartz ML, Drew RL, Chazin-Caldie M. Laparoscopic Roux-en-Y gastric bypass: preoperative determinants of prolonged operative times, conversion to open gastric bypasses, and postoperative complications. Obes Surg. 2003;13(5):734\u20138.","journal-title":"Obes Surg"},{"issue":"1","key":"726_CR16","first-page":"1","volume":"15","author":"A Iannelli","year":"2019","unstructured":"Iannelli A, Treacy P, Sebastianelli L, Schiavo L, Martini F. Perioperative complications of sleeve gastrectomy: review of the literature. J Minim Access Surg. 2019;15(1):1\u20137.","journal-title":"J Minim Access Surg"},{"key":"726_CR17","doi-asserted-by":"crossref","unstructured":"Mechanick JI, Apovian C, Brethauer S, Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures \u2013 2019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists - executive summary. Endocr Pract. 2019;25(12):1346\u20131359.","DOI":"10.4158\/GL-2019-0406"},{"issue":"1","key":"726_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13679-017-0242-2","volume":"6","author":"S Jumbe","year":"2017","unstructured":"Jumbe S, Hamlet C, Meyrick J. Psychological Aspects of Bariatric Surgery as a Treatment for Obesity. Curr Obes Rep. 2017;6(1):71\u20138.","journal-title":"Curr Obes Rep"},{"issue":"5","key":"726_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamasurg.2017.5025","volume":"153","author":"AP Courcoulas","year":"2018","unstructured":"Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, Gourash W, Horlick M, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, Singh A, Spaniolas K, Thirlby R, Wolfe BM, Yanovski SZ. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018;153(5):427\u201334.","journal-title":"JAMA Surg"},{"issue":"2","key":"726_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/jc.2014-3415","volume":"100","author":"CM Apovian","year":"2015","unstructured":"Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD. Endocrine Society. Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"726_CR21","doi-asserted-by":"publisher","first-page":"1043595","DOI":"10.3389\/fendo.2022.1043595","volume":"13","author":"E Lucas","year":"2023","unstructured":"Lucas E, Simmons O, Tchang B, Aronne L. Pharmacologic management of weight regain following bariatric surgery. Front Endocrinol (Lausanne). 2023;13:1043595.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"726_CR22","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1007\/s00464-024-11191-1","volume":"38","author":"S Docimo Jr","year":"2024","unstructured":"Docimo S Jr, Shah J, Warren G, Ganam S, Sujka J, DuCoin C. A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point? Surg Endosc. 2024;38(11):6560\u20135.","journal-title":"Surg Endosc"},{"issue":"3","key":"726_CR23","doi-asserted-by":"publisher","first-page":"102427","DOI":"10.1016\/j.dsx.2022.102427","volume":"16","author":"R Shetty","year":"2022","unstructured":"Shetty R, Basheer FT, Poojari PG, Thunga G, Chandran VP, Acharya LD. Adverse drug reactions of GLP-1 agonists: A systematic review of case reports. Diabetes Metab Syndr. 2022;16(3):102427.","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"726_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2337\/dc22-1148","volume":"46","author":"J Bezin","year":"2023","unstructured":"Bezin J, Gouverneur A, P\u00e9nichon M, Mathieu C, Garrel R, Hillaire-Buys D, Pariente A, Faillie JL. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care. 2023;46(2):384\u201390.","journal-title":"Diabetes Care"},{"issue":"11","key":"726_CR25","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2337\/dci24-0003","volume":"47","author":"DJ Drucker","year":"2024","unstructured":"Drucker DJ. Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity. Diabetes Care. 2024;47(11):1873\u201388.","journal-title":"Diabetes Care"},{"issue":"2","key":"726_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.diabres.2014.01.010","volume":"103","author":"M Monami","year":"2014","unstructured":"Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E. Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials. Diabetes Res Clin Pract. 2014;103(2):269\u201375.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"726_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","volume":"182","author":"L He","year":"2022","unstructured":"He L, Wang J, Ping F, Yang N, Huang J, Li Y, Xu L, Li W, Zhang H. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. 2022;182(5):513\u20139.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"726_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S2468-1253(24)00188-2","volume":"9","author":"RJ Jalleh","year":"2024","unstructured":"Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M. Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. Lancet Gastroenterol Hepatol. 2024;9(10):957\u201364.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"726_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/anae.16306","volume":"79","author":"DA Milder","year":"2024","unstructured":"Milder DA, Milder TY, Liang SS, Kam PCA. Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice. Anaesthesia. 2024;79(7):735\u201347.","journal-title":"Anaesthesia"},{"issue":"9","key":"726_CR30","first-page":"e46197","volume":"15","author":"N Klair","year":"2023","unstructured":"Klair N, Patel U, Saxena A, Patel D, Ayesha IE, Monson NR, Ramphall S. What Is Best for Weight Loss? A Comparative Review of the Safety and Efficacy of Bariatric Surgery Versus Glucagon-Like Peptide-1 Analogue. Cureus. 2023;15(9):e46197.","journal-title":"Cureus"},{"issue":"8","key":"726_CR31","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s41591-024-03052-0","volume":"30","author":"Y Wolff Sagy","year":"2024","unstructured":"Wolff Sagy Y, Lavie G, Ramot N, Battat E, Arbel R, Reges O, Dicker D. Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nat Med. 2024;30(8):2337\u201342.","journal-title":"Nat Med"},{"issue":"8","key":"726_CR32","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF, STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553\u201364.","journal-title":"Diabetes Obes Metab"},{"key":"726_CR33","doi-asserted-by":"publisher","first-page":"101351","DOI":"10.1016\/j.molmet.2021.101351","volume":"57","author":"DJ Drucker","year":"2022","unstructured":"Drucker DJ. GLP-1 physiology informs the pharmacotherapy of obesity. Mol Metab. 2022;57:101351.","journal-title":"Mol Metab"},{"issue":"10019","key":"726_CR34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","volume":"387","author":"MJ Armstrong","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, Hazlehurst JM, Guo K, LEAN trial team, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, H\u00fcbscher SG, Newsome PN. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387(10019):679\u201390.","journal-title":"Lancet"},{"issue":"21","key":"726_CR35","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","volume":"392","author":"AJ Sanyal","year":"2025","unstructured":"Sanyal AJ, Newsome PN, Kliers I, \u00d8stergaard LH, Long MT, Kj\u00e6r MS, Cali AMG, Bugianesi E, Rinella ME, Roden M, Ratziu V, ESSENCE Study Group. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025;392(21):2089\u201399.","journal-title":"N Engl J Med"},{"issue":"6","key":"726_CR36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2337\/dc19-1892","volume":"43","author":"ML Hartman","year":"2020","unstructured":"Hartman ML, Sanyal AJ, Loomba R, Wilson JM, Nikooienejad A, Bray R, Karanikas CA, Duffin KL, Robins DA, Haupt A. Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes. Diabetes Care. 2020;43(6):1352\u20135.","journal-title":"Diabetes Care"},{"issue":"4","key":"726_CR37","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s11695-020-05160-5","volume":"31","author":"W El Ansari","year":"2021","unstructured":"El Ansari W, Elhag W. Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps-a Scoping Review. Obes Surg. 2021;31(4):1755\u201366.","journal-title":"Obes Surg"},{"issue":"6","key":"726_CR38","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s11695-022-06020-0","volume":"32","author":"RJ Franken","year":"2022","unstructured":"Franken RJ, Sluiter NR, Franken J, de Vries R, Souverein D, Gerdes VEA, de Brauw M. Treatment Options for Weight Regain or Insufficient Weight Loss After Sleeve Gastrectomy: a Systematic Review and Meta-analysis. Obes Surg. 2022;32(6):2035\u201346.","journal-title":"Obes Surg"},{"issue":"11","key":"726_CR39","doi-asserted-by":"publisher","first-page":"e13811","DOI":"10.1111\/obr.13811","volume":"25","author":"A Esparham","year":"2024","unstructured":"Esparham A, Mehri A, Dalili A, Richards J, Khorgami Z. Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis. Obes Rev. 2024;25(11):e13811.","journal-title":"Obes Rev"},{"issue":"20","key":"726_CR40","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1056\/NEJMp2400978","volume":"390","author":"EJ Emanuel","year":"2024","unstructured":"Emanuel EJ, Dellgren JL, McCoy MS, Persad G. Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists. N Engl J Med. 2024;390(20):1839\u201342.","journal-title":"N Engl J Med"},{"issue":"1","key":"726_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jama.2023.24945","volume":"331","author":"LJ Aronne","year":"2024","unstructured":"Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA. SURMOUNT-4 Investigators. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38\u201348.","journal-title":"JAMA"},{"issue":"2","key":"726_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11695-015-1769-5","volume":"26","author":"J van Wissen","year":"2016","unstructured":"van Wissen J, Bakker N, Doodeman HJ, Jansma EP, Bonjer HJ, Houdijk AP. Preoperative Methods to Reduce Liver Volume in Bariatric Surgery: a Systematic Review. Obes Surg. 2016;26(2):251\u20136.","journal-title":"Obes Surg"},{"issue":"5","key":"726_CR43","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s00464-021-08592-x","volume":"36","author":"MA Salman","year":"2022","unstructured":"Salman MA, Qassem MG, Aboul-Enein MS, A Ameen M, Abdallah A, Omar H, Hussein AM, Tourky MS, Monazea K, Hassan M, Salman A, Moustafa A, Shaaban A, Soliman HE, Sarhan A. Effect of preoperative diet regimen on liver size before laparoscopic sleeve gastrectomy in morbidly obese patients. Surg Endosc. 2022;36(5):2981\u20136.","journal-title":"Surg Endosc"},{"issue":"2","key":"726_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.soard.2024.08.037","volume":"21","author":"HF Lofton","year":"2025","unstructured":"Lofton HF, Maranga G, Hold R, Fielding G, Youn H, Gujral A, Heffron S, Fielding C. A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0\u00a0mg for weight recurrence after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2025;21(2):135\u201345.","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"726_CR45","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11695-023-06484-8","volume":"33","author":"AB Jensen","year":"2023","unstructured":"Jensen AB, Renstr\u00f6m F, Acz\u00e9l S, Folie P, Biraima-Steinemann M, Beuschlein F, Bilz S. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg. 2023;33(4):1017\u201325.","journal-title":"Obes Surg"},{"issue":"8","key":"726_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sj\u00f6str\u00f6m","year":"2007","unstructured":"Sj\u00f6str\u00f6m L, Narbro K, Sj\u00f6str\u00f6m CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, L\u00f6nroth H, N\u00e4slund I, Olbers T, Stenl\u00f6f K, Torgerson J, Agren G, Carlsson LM. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741\u201352.","journal-title":"N Engl J Med"},{"issue":"22","key":"726_CR47","first-page":"2416","volume":"310","author":"AP Courcoulas","year":"2013","unstructured":"Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, Horlick M, Kalarchian MA, King WC, Mitchell JE, Patterson EJ, Pender JR, Pomp A, Pories WJ, Thirlby RC, Yanovski SZ, Wolfe BM. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416\u201325.","journal-title":"JAMA"},{"issue":"12","key":"726_CR48","doi-asserted-by":"publisher","first-page":"828","DOI":"10.6061\/clinics\/2014(12)07","volume":"69","author":"MA Santo","year":"2014","unstructured":"Santo MA, Riccioppo D, Pajecki D, Cleva Rd, Kawamoto F, Cecconello I. Preoperative weight loss in super-obese patients: study of the rate of weight loss and its effects on surgical morbidity. Clin (Sao Paulo). 2014;69(12):828\u201334.","journal-title":"Clin (Sao Paulo)"},{"issue":"5","key":"726_CR49","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamasurg.2025.0001","volume":"160","author":"V Mathur","year":"2025","unstructured":"Mathur V, Wasden K, Shin TH, Medhati P, Nimeri AA, Tavakkoli A, Sheu EG. Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes. JAMA Surg. 2025;160(5):594\u20136.","journal-title":"JAMA Surg"},{"issue":"12","key":"726_CR50","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1136\/gutjnl-2023-330437","volume":"72","author":"M Saumoy","year":"2023","unstructured":"Saumoy M, Gandhi D, Buller S, Patel S, Schneider Y, Cote G, Kochman ML, Thiruvengadam NR, Sharaiha RZ. Cost-effectiveness of endoscopic, surgical and pharmacological obesity therapies: a microsimulation and threshold analyses. Gut. 2023;72(12):2250\u20139.","journal-title":"Gut"},{"issue":"11","key":"726_CR51","doi-asserted-by":"publisher","first-page":"e13087","DOI":"10.1111\/obr.13087","volume":"21","author":"M O\u2019Kane","year":"2020","unstructured":"O\u2019Kane M, Parretti HM, Pinkney J, Welbourn R, Hughes CA, Mok J, Walker N, Thomas D, Devin J, Coulman KD, Pinnock G, Batterham RL, Mahawar KK, Sharma M, Blakemore AI, McMillan I, Barth JH. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11):e13087.","journal-title":"Obes Rev"},{"issue":"Suppl 2","key":"726_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/dom.16364","volume":"27","author":"RW Thomsen","year":"2025","unstructured":"Thomsen RW, Mailhac A, L\u00f8hde JB, Potteg\u00e5rd A. Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies. Diabetes Obes Metab. 2025;27(Suppl 2):66\u201388.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"726_CR53","doi-asserted-by":"publisher","first-page":"e2457349","DOI":"10.1001\/jamanetworkopen.2024.57349","volume":"8","author":"PJ Rodriguez","year":"2025","unstructured":"Rodriguez PJ, Zhang V, Gratzl S, Do D, Goodwin Cartwright B, Baker C, Gluckman TJ, Stucky N, Emanuel EJ. Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity. JAMA Netw Open. 2025;8(1):e2457349.","journal-title":"JAMA Netw Open"},{"key":"726_CR54","doi-asserted-by":"crossref","unstructured":"Liu D, Xu J, Pu Y, Chen Y, Fumpa M, Du Q, Wan Q, Zhao R, Zhang G, Cheng Z, Widjaja J, Chen H, Chen Y. (2025). Preoperative semaglutide before sleeve gastrectomy compared to surgery alone is associated with greater short-term weight loss and dyslipidemia remission: a prospective non-randomized controlled trial. Int J Surg. 2025 Nov 14. Advance online publication.","DOI":"10.1097\/JS9.0000000000004001"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00726-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-026-00726-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00726-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:03:35Z","timestamp":1781161415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-026-00726-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["726"],"URL":"https:\/\/doi.org\/10.1007\/s13679-026-00726-3","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for this narrative review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not commissioned; externally peer-reviewed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and peer review"}}],"article-number":"46"}}